<DOC>
	<DOC>NCT02415777</DOC>
	<brief_summary>A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of 'URSA SOFT CAP. (UDCA-003)' in fatigue patients with liver dysfunction</brief_summary>
	<brief_title>Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<mesh_term>Thiamine</mesh_term>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<criteria>CIS greater than or equal to 76, HADS less than or equal to 10 ALT greater than upper limit of normal OR fatty liver on US Subjects who have diseases that can cause fatigue Subjects who are taking medication that can cause fatigue</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>